Plan panel sets $100-bn target for pharma sector

The has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the (2012-17) by the panel, the objective of the sector will be to cross the $60-billion mark in 2017, which will be five per cent of the global pharma industry.

The Indian pharmaceutical industry is valued at $22 billion, and is the third largest in terms of volume and 13th in terms of value globally.

According to the draft plan, the exports of pharma-products should rise to Rs 1.3 lakh crore by the end of the 12th Five Year Plan. “The sector should employ 1.5 million people by 2015, 1.9 million by 2018 and 2.4 million people by 2022,” it added.

According to the draft plan, which will be submitted to the National Development Council (NDC) tomorrow, all the Central public sector undertakings (CPSUs) involved in production of pharmaceutical products should be self-sustaining by 2020.

In order to achieve the target, the Planning Commission has recommended various steps which include capacity building of private sector to meet (World Health Organization-Good Manufacturing Practice) standards and other international manufacturing requirements.

The other recommendations include developing a common infrastructure in drug discovery and development such as manufacturing, distribution, exports and medical devices.

image
Business Standard
177 22
Business Standard

Plan panel sets $100-bn target for pharma sector

Press Trust Of India  |  New Delhi 



The has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the (2012-17) by the panel, the objective of the sector will be to cross the $60-billion mark in 2017, which will be five per cent of the global pharma industry.

The Indian pharmaceutical industry is valued at $22 billion, and is the third largest in terms of volume and 13th in terms of value globally.

According to the draft plan, the exports of pharma-products should rise to Rs 1.3 lakh crore by the end of the 12th Five Year Plan. “The sector should employ 1.5 million people by 2015, 1.9 million by 2018 and 2.4 million people by 2022,” it added.

According to the draft plan, which will be submitted to the National Development Council (NDC) tomorrow, all the Central public sector undertakings (CPSUs) involved in production of pharmaceutical products should be self-sustaining by 2020.

In order to achieve the target, the Planning Commission has recommended various steps which include capacity building of private sector to meet (World Health Organization-Good Manufacturing Practice) standards and other international manufacturing requirements.

The other recommendations include developing a common infrastructure in drug discovery and development such as manufacturing, distribution, exports and medical devices.

RECOMMENDED FOR YOU

Plan panel sets $100-bn target for pharma sector

The Planning Commission has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the 12th Five-Year Plan (2012-17) by the panel, the objective of the sector will be to cross the $60-billion mark in 2017, which will be five per cent of the global pharma industry.

The has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the (2012-17) by the panel, the objective of the sector will be to cross the $60-billion mark in 2017, which will be five per cent of the global pharma industry.

The Indian pharmaceutical industry is valued at $22 billion, and is the third largest in terms of volume and 13th in terms of value globally.

According to the draft plan, the exports of pharma-products should rise to Rs 1.3 lakh crore by the end of the 12th Five Year Plan. “The sector should employ 1.5 million people by 2015, 1.9 million by 2018 and 2.4 million people by 2022,” it added.

According to the draft plan, which will be submitted to the National Development Council (NDC) tomorrow, all the Central public sector undertakings (CPSUs) involved in production of pharmaceutical products should be self-sustaining by 2020.

In order to achieve the target, the Planning Commission has recommended various steps which include capacity building of private sector to meet (World Health Organization-Good Manufacturing Practice) standards and other international manufacturing requirements.

The other recommendations include developing a common infrastructure in drug discovery and development such as manufacturing, distribution, exports and medical devices.

image
Business Standard
177 22

More News

  • Govt girds for next RCEP trade talks Govt girds up for next round of RCEP talks
  • Revised DTAA between India and Cyprus gets nod
Widgets Magazine

Widgets Magazine

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard